| miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells R Spizzo, MS Nicoloso, L Lupini, Y Lu, J Fogarty, S Rossi, B Zagatti, ... Cell Death & Differentiation 17 (2), 246-254, 2010 | 297 | 2010 |
| Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 S Marchi, L Lupini, S Patergnani, A Rimessi, S Missiroli, M Bonora, ... Current Biology 23 (1), 58-63, 2013 | 248 | 2013 |
| Oncogenic role of miR-483-3p at the IGF2/483 locus A Veronese, L Lupini, J Consiglio, R Visone, M Ferracin, F Fornari, ... Cancer research 70 (8), 3140-3149, 2010 | 248 | 2010 |
| Liver tumorigenicity promoted by microRNA‐221 in a mouse transgenic model E Callegari, BK Elamin, F Giannone, M Milazzo, G Altavilla, F Fornari, ... Hepatology 56 (3), 1025-1033, 2012 | 215 | 2012 |
| Absolute quantification of cell-free microRNAs in cancer patients M Ferracin, L Lupini, I Salamon, E Saccenti, MV Zanzi, A Rocchi, ... Oncotarget 6 (16), 14545, 2015 | 140 | 2015 |
| MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia M Ferracin, B Zagatti, L Rizzotto, F Cavazzini, A Veronese, M Ciccone, ... Molecular cancer 9, 1-14, 2010 | 138 | 2010 |
| Quantification of circulating miRNAs by droplet digital PCR: comparison of EvaGreen-and TaqMan-based chemistries E Miotto, E Saccenti, L Lupini, E Callegari, M Negrini, M Ferracin Cancer Epidemiology, Biomarkers & Prevention 23 (12), 2638-2642, 2014 | 109 | 2014 |
| In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI GM Rigolin, M Cavallari, FM Quaglia, L Formigaro, E Lista, A Urso, ... Blood, The Journal of the American Society of Hematology 129 (26), 3495-3498, 2017 | 99 | 2017 |
| miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression M Ferracin, C Bassi, M Pedriali, S Pagotto, L D’Abundo, B Zagatti, F Corrà, ... Molecular cancer 12, 1-10, 2013 | 98 | 2013 |
| Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma F Moshiri, A Salvi, L Gramantieri, A Sangiovanni, P Guerriero, G De Petro, ... Oncotarget 9 (20), 15350, 2018 | 87 | 2018 |
| Mutated β-catenin evades a microRNA-dependent regulatory loop A Veronese, R Visone, J Consiglio, M Acunzo, L Lupini, T Kim, M Ferracin, ... Proceedings of the National Academy of Sciences 108 (12), 4840-4845, 2011 | 69 | 2011 |
| Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients L Lupini, C Bassi, J Mlcochova, G Musa, M Russo, ... BMC cancer 15, 1-11, 2015 | 67 | 2015 |
| Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma F Moshiri, E Callegari, L D'Abundo, F Corrà, L Lupini, S Sabbioni, ... Gastroenterology and Hepatology From Bed to Bench 7 (1), 43, 2014 | 65 | 2014 |
| miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs L Lupini, C Bassi, M Ferracin, N Bartonicek, L D'Abundo, B Zagatti, ... Frontiers in genetics 4, 64, 2013 | 64 | 2013 |
| Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations GM Rigolin, E Saccenti, C Bassi, L Lupini, FM Quaglia, M Cavallari, ... Journal of Hematology & Oncology 9, 1-9, 2016 | 55 | 2016 |
| Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma L Lupini, F Pepe, M Ferracin, C Braconi, E Callegari, S Pagotto, R Spizzo, ... Oncotarget 7 (21), 31361, 2016 | 51 | 2016 |
| Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: clinical and biologic correlations GM Rigolin, I del Giudice, L Formigaro, E Saccenti, S Martinelli, ... Genes, Chromosomes and Cancer 54 (12), 818-826, 2015 | 48 | 2015 |
| In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics GM Rigolin, E Saccenti, E Guardalben, M Cavallari, L Formigaro, ... British Journal of Haematology 181 (2), 229-233, 2018 | 45 | 2018 |
| Circulating non-coding RNA as biomarkers in colorectal cancer M Ferracin, L Lupini, A Mangolini, M Negrini Non-coding RNAs in Colorectal Cancer, 171-181, 2016 | 34 | 2016 |
| Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer R Roncarati, L Lupini, E Miotto, E Saccenti, S Mascetti, L Morandi, C Bassi, ... Molecular oncology 14 (9), 2163-2175, 2020 | 23 | 2020 |
